[1]CurrentPatentAssignee:XINFAPHARMACEUTICALCOLTD-CN110734368,2020,ALocationinpatent:Paragraph0070-0076;0082-0084
[1]CurrentPatentAssignee:CANGZHOUDONGENTECH-CN114956972,2022,ALocationinpatent:Paragraph0095-0098
[2]CurrentPatentAssignee:XINFAPHARMACEUTICALCOLTD-CN110734368,2020,ALocationinpatent:Paragraph0077-0078
[1]CurrentPatentAssignee:XINFAPHARMACEUTICALCOLTD-CN110734368,2020,A
[2]CurrentPatentAssignee:XINFAPHARMACEUTICALCOLTD-CN110734368,2020,A
[1]CurrentPatentAssignee:XINFAPHARMACEUTICALCOLTD-CN110734368,2020,A
[2]CurrentPatentAssignee:XINFAPHARMACEUTICALCOLTD-CN110734368,2020,A
Title: Drug delivery systems for the topical treatment of cutaneous leishmaniasis.
Journal: Expert opinion on drug delivery 20120901
Title: Point mutations in the Theileria annulata cytochrome b gene is associated with buparvaquone treatment failure.
Journal: Veterinary parasitology 20120706
Title: Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi.
Journal: Experimental parasitology 20120301
Title: Evaluation and structure-activity relationship study of acute toxicity of naphthoquinones to Photobacterium phosphoreum, Photobacterium T3B.
Journal: Bulletin of environmental contamination and toxicology 20100801
Title: In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone.
Journal: Drug development and industrial pharmacy 20100601
Title: Cytoplasmic sequestration of p53 promotes survival in leukocytes transformed by Theileria.
Journal: Oncogene 20100527
Title: In vivo evidence for the resistance of Theileria annulata to buparvaquone.
Journal: Veterinary parasitology 20100511
Title: The protozoan parasite Theileria annulata alters the differentiation state of the infected macrophage and suppresses musculoaponeurotic fibrosarcoma oncogene (MAF) transcription factors.
Journal: International journal for parasitology 20090801
Title: Optimization and validation of RP-HPLC-UV method with solid-phase extraction for determination of buparvaquone in human and rabbit plasma: application to pharmacokinetic study.
Journal: Biomedical chromatography : BMC 20080501
Title: [Therapeutic efficacy of buparvaquone (buparvon) in cattle with theileriosis].
Journal: Turkiye parazitolojii dergisi 20080101
Title: In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs.
Journal: The Journal of antimicrobial chemotherapy 20071001
Title: Clinical, haematological and therapeutic studies on tropical theileriosis in water buffaloes (Bubalus bubalis) in Egypt.
Journal: Veterinary parasitology 20070531
Title: Development and validation of RP-HPLC-UV method for simultaneous determination of buparvaquone, atenolol, propranolol, quinidine and verapamil: a tool for the standardization of rat in situ intestinal permeability studies.
Journal: Journal of pharmaceutical and biomedical analysis 20070312
Title: Topical buparvaquone formulations for the treatment of cutaneous leishmaniasis.
Journal: The Journal of pharmacy and pharmacology 20070101
Title: Clinical efficacy and plasma concentrations of two formulations of buparvaquone in cattle infected with East Coast fever (Theileria parva infection).
Journal: Research in veterinary science 20060801
Title: Evaluation of buparvaquone (BUTA-Kel KELA, Belgium) as a treatment of East Coast fever in cattle, in the peri-urban of Dar Es Salaam city, Tanzania.
Journal: Veterinary parasitology 20060630
Title: Characterization of nebulized buparvaquone nanosuspensions--effect of nebulization technology.
Journal: Journal of drug targeting 20050101
Title: Design, synthesis and in vitro evaluation of novel water-soluble prodrugs of buparvaquone.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20041001
Title: Synthesis and antileishmanial activity of novel buparvaquone oxime derivatives.
Journal: Bioorganic & medicinal chemistry 20040701
Title: The effect of dexamethasone and promethazine in combination with buparvaquone in the management of East Coast fever.
Journal: The Onderstepoort journal of veterinary research 20040601
Title: Cerebral theileriosis in a Holstein calf.
Journal: The Veterinary record 20040424
Title: Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone.
Journal: Journal of medicinal chemistry 20040101
Title: In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys.
Journal: The Journal of veterinary medical science 20031101
Title: Theileria parva-transformed T cells show enhanced resistance to Fas/Fas ligand-induced apoptosis.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20030801
Title: Apoptosis of Theileria-infected lymphocytes induced upon parasite death involves activation of caspases 9 and 3.
Journal: Biochimie 20030801
Title: Transition metal complexes of buparvaquone as potent new antimalarial agents. 1. Synthesis, X-ray crystal-structures, electrochemistry and antimalarial activity against Plasmodium falciparum.
Journal: Journal of inorganic biochemistry 20030701
Title: Constitutive exclusion of Csk from Hck-positive membrane microdomains permits Src kinase-dependent proliferation of Theileria-transformed B lymphocytes.
Journal: Blood 20030301
Title: Hijacking of host cell IKK signalosomes by the transforming parasite Theileria.
Journal: Science (New York, N.Y.) 20021101
Title: Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability.
Journal: International journal of pharmaceutics 20020426
Title: Production and characterisation of mucoadhesive nanosuspensions for the formulation of bupravaquone.
Journal: International journal of pharmaceutics 20010219
Title: Müller J, et al. Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice. Int J Parasitol Drugs Drug Resist. 2015 Feb 13;5(1):16-25.
Title: Reimão JQ, et al. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi. Exp Parasitol. 2012 Mar;130(3):195-9.
Title: Garnier T, et al. In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs. J Antimicrob Chemother. 2007 Oct;60(4):802-10.
